Post Profile






Thousands of breast cancer patients missing out on 43p-a-day drug

Research suggests confusion over funding of bisphosphonates means some women are not receiving the drug that could prevent their disease spreading Thousands of women with postmenopausal breast cancer are missing out on 43p-a-day drugs that could prevent their disease spreading, research suggests. A poll of cancer specialists for the charity Breast Cancer Now found confusion over who funds bisphosphonates – cheap drugs typically used to treat osteoporosis.
read more

share

Related Posts


Side Effects Of Breast Cancer Drugs Can Be So Bad Women End Treatment And Risk Return Of Cancer

Health : Medical News Today

Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring? The first study to actually ask the women themselves -- as well as the largest, ...

Breast Cancer Prevention Drug Shown to Decrease Bone Density and Structure in Postmenopausal Women

Health : Newswise Medical News

Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.

Drug Used To Protect Bone May Extend Survival In Older Breast Cancer Patients

Health : Medical News Today

The AZURE trial, led by Professor Robert Coleman from the University of Sheffield, has revealed that the bisphosphonate drug zoledronic acid boosts disease-free survival in postmenopausal breast cancer patients but may have an adver...

Researchers Receive $4.4 Million in Federal Funds to Determine If Statin Drug Can Prevent Heart Problems in Breast Cancer Patients

Health : Newswise Medical News

Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer.

Two classes of inexpensive generic drugs can reduce breast cancer deaths, new research shows

Academics / General Science : ScienceDaily: Science Society

Two different classes of drugs, aromatase inhibitors and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer, two recent studies indicate. Moreover, the researchers suggest that the...

Comments


Copyright © 2016 Regator, LLC